Johanna Mercier
Fortuna: 18 M $ al 31/05/2026
Fortuna: 18 M $ al 31/05/2026
Johanna Mercier es directora comercial de Gilead Sciences, Inc. y miembro de World 50, Inc. Forma parte del Consejo de Administración de Neurocrine Biosciences, Inc., del Leonard D Schaeffer Center For Health Policy & Economics y del Robert Wood Johnson University Hospital, Inc. La Sra. Mercier trabajó anteriormente como Presidenta Comercial de Estados Unidos en Bristol Myers Squibb Co. Se licenció en la Universidad de Montral y obtuvo un MBA en la Universidad de Concordia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GILEAD SCIENCES, INC. 0,01 % | 15/06/2026 | 124.234 ( 0,01 % ) | 17 M $ | 31/05/2026 |
| 27/05/2026 | 6.853 ( 0,01 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/07/2019 |
| NEUROCRINE BIOSCIENCES, INC. | Director/Miembro de la Junta | 15/04/2021 |
| ARCUS BIOSCIENCES, INC. | Director/Miembro de la Junta | 29/01/2024 |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Director/Miembro de la Junta | - |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Director/Miembro de la Junta | - |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/06/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Technology Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.